Prescribing of β-adrenoceptor antagonists in asthma: An observational study

Thorax

Volumn 66, Issue 6, 2011, Pages 502-507

  Morales, Daniel R ^a   Guthrie, Bruce ^b   Lipworth, Brian J ^b   Donnan, Peter T ^b   Jackson, Cathy ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; CELIPROLOL; CORTICOSTEROID; LABETALOL; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METOPROLOL; NEBIVOLOL; OXPRENOLOL; PREDNISOLONE; PROPRANOLOL; SOTALOL; THEOPHYLLINE; TIMOLOL;

ADULT; AGED; ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG USE; FEMALE; FOLLOW UP; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 79956366638     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2011-200067     Document Type: Article

References (21)

1. Masoli M, Fabian D, Holt S, et al; Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59:469-78.
2. British Thoracic Society Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma. Thorax 2008;63(Suppl 4):iv1-121.
3. Global Initiative for Asthma [Internet]. Global Strategy for Asthma Management and Prevention. http://www.ginasthma.org/ (accessed 31 Jan 2010).
4. Chowdhury BA, Dal Pan G. The FDA and safe use of long-acting beta-agonists in the treatment of asthma. N Engl J Med 2010;362:1169-71.
5. Schwartz S, Davies S, Juers JA. Life-threatening cold and exercise-induced asthma potentiated by administration of propranolol. Chest 1980;78:100-1. (Pubitemid 10090332)
6. Vatrella A, Parrella R, Pelaia G, et al. Effects of non- bronchoconstrictive doses of inhaled propranolol on airway responsiveness to methacholine. Eur J Clin Pharmacol 2001;57:99-104. (Pubitemid 32449128)
7. Callaerts-Vegh Z, Evans KL, Dudekula N, et al. Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma. Proc Natl Acad Sci USA 2004;101:4948-53. (Pubitemid 38469183)
8. Lin R, Peng H, Nguyen LP, et al. Changes in beta 2-adrenoceptor and other signaling proteins produced by chronic administration of 'beta-blockers' in a murine asthma model. Pulm Pharmacol Ther 2008;21:115-24.
9. Nguyen LP, Omoluabi O, Parra S, et al. Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model. Am J Respir Cell Mol Biol 2008;38:256-62. (Pubitemid 351567693)
10. Hanania NA, Singh S, El-Wali R, et al. The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study. Pulm Pharmacol Ther 2008;21:134-41.
11. Baker JG. The selectivity of β-adrenoceptor antagonists at the human b1, b2 and β3 adrenoceptors. Br J Pharmacol 2005;144:317-22.
12. Salpeter SR, Ormiston TM, Salpeter EE. Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis. Ann Intern Med 2002;137:715-25. (Pubitemid 35265315)
13. Lipworth BJ, Williamson PA. Beta blockers for asthma: a double-edged sword. Lancet 2009;373:104-5.
14. Evans JM, Hayes JL, Lipworth BJ, et al. Potentially hazardous co-prescribing of beta-adrenoceptor antagonists and agonists in the community. Br J Gen Pract 1996;46:423-5. (Pubitemid 26245294)
15. Helms PJ, Ekins Daukes S, Taylor MW, et al. Utility of routinely acquired primary care data for paediatric disease epidemiology and pharmacoepidemiology. Br J Clin Pharmacol 2005;59:684-90. (Pubitemid 40835502)
16. Cohn JN, Fowler MB, Bristow MR, et al. Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group. J Card Fail 1997;3:173-9. (Pubitemid 127674849)
17. Salpeter S, Ormiston T, Salpeter E. Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005;(4):CD003566.
18. Anon. Joint Formulary Committee, British National Formulary. 59th edn. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 2010.
19. Lima DR, Turner P. Beta-blocking drugs increase responsiveness to prostacyclin in hypertensive patients. Lancet 1982;2:444. (Pubitemid 12039860)
20. Lima DR, Turner P. Propranolol increases reduced beta-receptor function in severely anxious patients. Lancet 1983;2:1505. (Pubitemid 14203393)
21. Scottish Public Health Observatory. Asthma: NHS board data, 2010. http://www.scotpho.org.uk/home/Healthwell-beinganddisease/asthma/asthma-data/ asthma-nhsboarddata.asp (accessed 5 Nov 2010).